265 related articles for article (PubMed ID: 27323034)
1. Genetic polymorphisms and haplotype of hormone-related genes are associated with the risk of breast cancer in Chinese women.
Pan Z; Fu Z; Song Q; Cao W; Cheng W; Xu X
Genet Mol Res; 2016 May; 15(2):. PubMed ID: 27323034
[TBL] [Abstract][Full Text] [Related]
2. Polymorphisms associated with circulating sex hormone levels in postmenopausal women.
Dunning AM; Dowsett M; Healey CS; Tee L; Luben RN; Folkerd E; Novik KL; Kelemen L; Ogata S; Pharoah PD; Easton DF; Day NE; Ponder BA
J Natl Cancer Inst; 2004 Jun; 96(12):936-45. PubMed ID: 15199113
[TBL] [Abstract][Full Text] [Related]
3. Association of genetic polymorphisms of ER-alpha and the estradiol-synthesizing enzyme genes CYP17 and CYP19 with breast cancer risk in Chinese women.
Zhang L; Gu L; Qian B; Hao X; Zhang W; Wei Q; Chen K
Breast Cancer Res Treat; 2009 Mar; 114(2):327-38. PubMed ID: 18629629
[TBL] [Abstract][Full Text] [Related]
4. A multigenic study on breast cancer risk associated with genetic polymorphisms of ER Alpha, COMT and CYP19 gene in BRCA1/BRCA2 negative Shanghai women with early onset breast cancer or affected relatives.
Hu Z; Song CG; Lu JS; Luo JM; Shen ZZ; Huang W; Shao ZM
J Cancer Res Clin Oncol; 2007 Dec; 133(12):969-78. PubMed ID: 17562079
[TBL] [Abstract][Full Text] [Related]
5. Genetic polymorphisms in the catechol estrogen metabolism pathway and breast cancer risk.
Reding KW; Weiss NS; Chen C; Li CI; Carlson CS; Wilkerson HW; Farin FM; Thummel KE; Daling JR; Malone KE
Cancer Epidemiol Biomarkers Prev; 2009 May; 18(5):1461-7. PubMed ID: 19383894
[TBL] [Abstract][Full Text] [Related]
6. A comprehensive haplotype analysis of CYP19 and breast cancer risk: the Multiethnic Cohort.
Haiman CA; Stram DO; Pike MC; Kolonel LN; Burtt NP; Altshuler D; Hirschhorn J; Henderson BE
Hum Mol Genet; 2003 Oct; 12(20):2679-92. PubMed ID: 12944421
[TBL] [Abstract][Full Text] [Related]
7. Genetic polymorphisms of estrogen receptor alpha, CYP19, catechol-O-methyltransferase are associated with familial prostate carcinoma risk in a Japanese population.
Suzuki K; Nakazato H; Matsui H; Koike H; Okugi H; Kashiwagi B; Nishii M; Ohtake N; Nakata S; Ito K; Yamanaka H
Cancer; 2003 Oct; 98(7):1411-6. PubMed ID: 14508827
[TBL] [Abstract][Full Text] [Related]
8. Association of germline variation in CCNE1 and CDK2 with breast cancer risk, progression and survival among Chinese Han women.
Han JY; Wang H; Xie YT; Li Y; Zheng LY; Ruan Y; Song AP; Tian XX; Fang WG
PLoS One; 2012; 7(11):e49296. PubMed ID: 23185313
[TBL] [Abstract][Full Text] [Related]
9. HapMap-based study on the association between MPO and GSTP1 gene polymorphisms and lung cancer susceptibility in Chinese Han population.
Gu JD; Hua F; Mei CR; Zheng DJ; Wang GF; Zhou QH
Acta Pharmacol Sin; 2014 May; 35(5):636-44. PubMed ID: 24786234
[TBL] [Abstract][Full Text] [Related]
10. Association between polymorphisms in estrogen metabolism genes and breast cancer development in Chinese women: A prospective case-control study.
Qiu J; Du Z; Liu J; Zhou Y; Liang F; Lü Q
Medicine (Baltimore); 2018 Nov; 97(47):e13337. PubMed ID: 30461653
[TBL] [Abstract][Full Text] [Related]
11. A Meta-Analysis of the Association between ESR1 Genetic Variants and the Risk of Breast Cancer.
Li T; Zhao J; Yang J; Ma X; Dai Q; Huang H; Wang L; Liu P
PLoS One; 2016; 11(4):e0153314. PubMed ID: 27070141
[TBL] [Abstract][Full Text] [Related]
12. BRCA1 breast cancer risk is modified by CYP19 polymorphisms in Ashkenazi Jews.
Raskin L; Lejbkowicz F; Barnett-Griness O; Dishon S; Almog R; Rennert G
Cancer Epidemiol Biomarkers Prev; 2009 May; 18(5):1617-23. PubMed ID: 19366906
[TBL] [Abstract][Full Text] [Related]
13. Comparison of genetic variation of breast cancer susceptibility genes in Chinese and German populations.
Barzan D; Veldwijk MR; Herskind C; Li Y; Zhang B; Sperk E; Du WD; Zhang XJ; Wenz F
Eur J Hum Genet; 2013 Nov; 21(11):1286-92. PubMed ID: 23486537
[TBL] [Abstract][Full Text] [Related]
14. Dietary isoflavone intake, polymorphisms in the CYP17, CYP19, 17beta-HSD1, and SHBG genes, and risk of breast cancer in case-control studies in Japanese, Japanese Brazilians, and non-Japanese Brazilians.
Iwasaki M; Hamada GS; Nishimoto IN; Netto MM; Motola J; Laginha FM; Kasuga Y; Yokoyama S; Onuma H; Nishimura H; Kusama R; Kobayashi M; Ishihara J; Yamamoto S; Hanaoka T; Tsugane S
Nutr Cancer; 2010; 62(4):466-75. PubMed ID: 20432167
[TBL] [Abstract][Full Text] [Related]
15. IL-1RN gene polymorphisms are associated with breast cancer risk in a Chinese Han population.
Jin T; Cao W; Zuo X; Li M; Yang Y; Liang T; Yang H; Zhao X; Yang D
J Gene Med; 2017 Dec; 19(12):. PubMed ID: 29047186
[TBL] [Abstract][Full Text] [Related]
16. The
Lv F; Huang W; Wang Y
Genet Test Mol Biomarkers; 2021 Jul; 25(7):486-495. PubMed ID: 34280004
[No Abstract] [Full Text] [Related]
17. Glutathione S-transferase P1 rs1695 A>G polymorphism and breast cancer risk: evidence from a meta-analysis.
Kuang M; Xu W; Cao CX; Shen LL; Chang J; Zhang XL; Chen JF; Tang CJ
Genet Mol Res; 2016 Jun; 15(2):. PubMed ID: 27323180
[TBL] [Abstract][Full Text] [Related]
18. CYP19 (aromatase) haplotypes and endometrial cancer risk.
Paynter RA; Hankinson SE; Colditz GA; Kraft P; Hunter DJ; De Vivo I
Int J Cancer; 2005 Aug; 116(2):267-74. PubMed ID: 15800924
[TBL] [Abstract][Full Text] [Related]
19. Association of CYP17, CYP19, CYP1B1, and COMT polymorphisms with serum and urinary sex hormone concentrations in postmenopausal women.
Tworoger SS; Chubak J; Aiello EJ; Ulrich CM; Atkinson C; Potter JD; Yasui Y; Stapleton PL; Lampe JW; Farin FM; Stanczyk FZ; McTiernan A
Cancer Epidemiol Biomarkers Prev; 2004 Jan; 13(1):94-101. PubMed ID: 14744739
[TBL] [Abstract][Full Text] [Related]
20. A CYP19 (aromatase) polymorphism is associated with increased premenopausal breast cancer risk.
Talbott KE; Gammon MD; Kibriya MG; Chen Y; Teitelbaum SL; Long CM; Gurvich I; Santella RM; Ahsan H
Breast Cancer Res Treat; 2008 Oct; 111(3):481-7. PubMed ID: 17975727
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]